跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
盐酸缬更昔洛韦片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Valganciclovir Hydrochloride Tablets
Approved
化学药品
Valganciclovir Hydrochloride Tablets
HETERO LABS LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Jan 19, 2023
Approval ID
ceb260c46ea6ada2
Company
HETERO LABS LIMITED
Type
化学药品
Approval Details
Approval Id
ceb260c46ea6ada2
Approval Number
国药准字HJ20230002
Generic Name
盐酸缬更昔洛韦片
Generic Name En
Valganciclovir Hydrochloride Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
450mg(按C₁₄H₂₂N₆O₅计)
Reg Date
2023-01-19
Expired Date
2028-01-18
Company Name
HETERO LABS LIMITED
Production Company Name
HETERO LABS LIMITED
Company Detail Path
/organization/hetero-labs-limited
Production Company Detail Path
/organization/hetero-labs-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 19, 2023
Approval ID
ceb260c46ea6ada2
Type
化学药品
Back to NMPA Approvals